title: Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids.
authors.forename: G
authors.initials: G
authors.lastname: Lönnerholm
authors.forename: A
authors.initials: A
authors.lastname: Nordgren
authors.forename: B-M
authors.initials: BM
authors.lastname: Frost
authors.forename: O G
authors.initials: OG
authors.lastname: Jonsson
authors.forename: J
authors.initials: J
authors.lastname: Kanerva
authors.forename: R
authors.initials: R
authors.lastname: Nygaard
authors.forename: K
authors.initials: K
authors.lastname: Schmiegelow
authors.forename: R
authors.initials: R
authors.lastname: Larsson
authors.forename: E
authors.initials: E
authors.lastname: Forestier
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D001215:Asparaginase / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D002869:Chromosome Aberrations; D002890:Chromosomes, Human, Pair 20; D002899:Chromosomes, Human, Pair 9; D003561:Cytarabine / Q000494:pharmacology; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D006801:Humans; D007223:Infant; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics*
chemical_list: D000305:Adrenal Cortex Hormones; D003561:Cytarabine; D001215:Asparaginase